PortfoliosLab logo

VanEck Vectors Pharmaceutical ETF

PPH
ETF · Currency in USD
ISIN
US92189F6925
CUSIP
92189F692
Issuer
VanEck
Inception Date
Dec 20, 2011
Region
Developed Markets (Broad)
Category
Health & Biotech Equities
Expense Ratio
0.36%
Index Tracked
MVIS US Listed Pharmaceutical 25 Index
ETF Home Page
www.vaneck.com
Asset Class
Equity

Asset Class Size

Multi-Cap

Asset Class Style

Blend

PPHPrice Chart


Chart placeholderClick Calculate to get results

PPHPerformance

The chart shows the growth of $10,000 invested in VanEck Vectors Pharmaceutical ETF on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $27,275 for a total return of roughly 172.75%. All prices are adjusted for splits and dividends.


PPH (VanEck Vectors Pharmaceutical ETF)
Benchmark (S&P 500)

PPHReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M2.64%
6M7.67%
YTD13.77%
1Y23.30%
5Y8.24%
10Y10.41%

PPHMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

PPHSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current VanEck Vectors Pharmaceutical ETF Sharpe ratio is 1.63. A Sharpe ratio greater than 1.0 is considered acceptable.

The chart below displays rolling 12-month Sharpe Ratio.


PPH (VanEck Vectors Pharmaceutical ETF)
Benchmark (S&P 500)

PPHDividends

VanEck Vectors Pharmaceutical ETF granted a 1.67% dividend yield in the last twelve months, as of Oct 23, 2021. The annual payout for that period amounted to $1.25 per share.


PeriodTTM20202019201820172016201520142013201220112010
Dividend$1.25$1.10$1.14$1.08$1.14$1.27$1.26$1.10$1.04$1.35$0.00$0.00

Dividend yield

1.67%1.66%1.77%1.97%1.92%2.43%1.93%1.71%1.95%3.39%0.00%0.00%

PPHDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


PPH (VanEck Vectors Pharmaceutical ETF)
Benchmark (S&P 500)

PPHWorst Drawdowns

The table below shows the maximum drawdowns of the VanEck Vectors Pharmaceutical ETF. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the VanEck Vectors Pharmaceutical ETF is 30.19%, recorded on Mar 23, 2020. It took 200 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-30.19%Aug 6, 20151165Mar 23, 2020200Jan 6, 20211365
-16.44%Jan 20, 201095Jun 4, 2010226Apr 27, 2011321
-15.23%May 19, 201158Aug 10, 201195Dec 23, 2011153
-8.98%Sep 25, 201416Oct 16, 201418Nov 11, 201434
-7.69%Oct 19, 201218Nov 15, 201235Jan 8, 201353
-7.32%Mar 5, 201428Apr 11, 201412Apr 30, 201440
-7.04%Jan 26, 202127Mar 4, 202145May 7, 202172
-6.91%May 2, 201222Jun 1, 201221Jul 2, 201243
-6.37%May 29, 201319Jun 24, 201322Jul 25, 201341
-6.34%Aug 18, 202139Oct 12, 2021

PPHVolatility Chart

Current VanEck Vectors Pharmaceutical ETF volatility is 12.05%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


PPH (VanEck Vectors Pharmaceutical ETF)
Benchmark (S&P 500)

Portfolios with VanEck Vectors Pharmaceutical ETF


Loading data...

More Tools for VanEck Vectors Pharmaceutical ETF